US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 15.810
  • -0.820-4.93%
Close Mar 25 16:00 ET
  • 15.880
  • +0.070+0.44%
Pre 04:59 ET
2.11BMarket Cap-7.67P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Centessa Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Centessa Pharmaceuticals Earnings Reports

  • Centessa Pharmaceuticals | 10-K: FY2024 Annual Report

    Mar 24 07:32 ET

  • Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

    Mar 24 07:11 ET

  • Centessa Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Feb 14 16:49 ET

  • Centessa Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 09:31 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Enerpac Tool
    EPAC
    +8.39%
    Precision Drilling
    PDS
    +2.04%
    Halozyme Therapeutics
    HALO
    +1.28%
    Workday
    WDAY
    +1.17%
    Lantheus
    LNTH
    +0.33%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 24, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data